Clinical Trials
20 trialsNCT04680117 2026-05-06
SevAsthma
Assistance Publique - Hôpitaux de Paris
Phase NA Completed
NCT00282516 2025-02-10
Asthma In-Home Monitoring (AIM) Trial
Tripler Army Medical Center
Phase NA Completed
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT03916237 2023-10-19
CREST
MetroHealth Medical Center
Phase NA Completed
NCT01760915 2023-08-02
University of Wisconsin Severe Asthma Research Program III
University of Wisconsin, Madison
Completed
NCT02517099 2023-03-06
PrIGMa
Imperial College London
Phase 2 Completed
NCT03797404 2023-01-20
REMOMEPO
Assistance Publique - Hôpitaux de Paris
Completed
NCT02808689 2021-04-01
FAst
The Cleveland Clinic
Phase NA Completed
NCT03369847 2019-07-18
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
New York City Health and Hospitals Corporation
Phase 4 Completed
NCT01898767 2019-03-28
Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses
University of Wisconsin, Madison
Completed
NCT02844842 2019-01-25
APOLO
Roxall Medicina España S.A
Completed
NCT02022761 2018-05-30
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma
Vaxart
Phase 1 Completed
NCT00455923 2018-02-05
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
GlaxoSmithKline
Phase 4 Completed
NCT02105012 2017-06-06
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
Pearl Therapeutics, Inc.
Phase 2 Completed
NCT00461500 2017-03-03
SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
GlaxoSmithKline
Phase 4 Completed
NCT01089322 2017-02-16
Risk Factors Associated to Difficult-to-control Asthma
University of Sao Paulo General Hospital
Phase 4 Completed
NCT00621946 2014-02-04
Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
University of Texas Southwestern Medical Center
Phase 4 Completed
NCT00646516 2011-01-24
Gemini Symbicort pMDI
AstraZeneca
Phase 3 Completed
NCT00785733 2010-12-02
NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART
AstraZeneca
Completed
NCT00850265 2009-03-27
Effect of Spacer in Extrafine Formoterol-Beclomethasone Treatment to Asthma
Hospital General de Requena
Phase NA Completed